IL126113A0 - Methods for treatment of allergic diseases with ige - Google Patents

Methods for treatment of allergic diseases with ige

Info

Publication number
IL126113A0
IL126113A0 IL12611397A IL12611397A IL126113A0 IL 126113 A0 IL126113 A0 IL 126113A0 IL 12611397 A IL12611397 A IL 12611397A IL 12611397 A IL12611397 A IL 12611397A IL 126113 A0 IL126113 A0 IL 126113A0
Authority
IL
Israel
Prior art keywords
ige
treatment
methods
allergic diseases
allergic
Prior art date
Application number
IL12611397A
Other languages
English (en)
Original Assignee
Genentech Inc
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Univ Johns Hopkins filed Critical Genentech Inc
Publication of IL126113A0 publication Critical patent/IL126113A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12611397A 1996-03-12 1997-03-06 Methods for treatment of allergic diseases with ige IL126113A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61422096A 1996-03-12 1996-03-12
PCT/US1997/003443 WO1997033616A1 (en) 1996-03-12 1997-03-06 Methods for treatment of allergic diseases with ige

Publications (1)

Publication Number Publication Date
IL126113A0 true IL126113A0 (en) 1999-05-09

Family

ID=24460327

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12611397A IL126113A0 (en) 1996-03-12 1997-03-06 Methods for treatment of allergic diseases with ige

Country Status (8)

Country Link
EP (1) EP0904108A1 (es)
JP (1) JP2001505181A (es)
AR (1) AR006202A1 (es)
AU (1) AU726143B2 (es)
CA (1) CA2246427A1 (es)
IL (1) IL126113A0 (es)
WO (1) WO1997033616A1 (es)
ZA (1) ZA971607B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
AU2065801A (en) * 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
GB0016441D0 (en) 2000-07-04 2000-08-23 Pharmagene Lab Limited Therapeutic method
US6787524B2 (en) 2000-09-22 2004-09-07 Tanox, Inc. CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies
AU2002316887A1 (en) * 2001-05-03 2002-11-18 Novartis Ag Anti-ige antibody to treat ocular allergies
GB201610198D0 (en) * 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
CN114028569B (zh) * 2021-12-20 2023-04-28 中国医学科学院基础医学研究所 免疫球蛋白IgE在诊断和/或治疗高血压中的用途
CN114504644B (zh) * 2021-12-24 2024-02-13 北京大学第一医院 抗IgE抗体在用于治疗腺样体肥大中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体

Also Published As

Publication number Publication date
CA2246427A1 (en) 1997-09-18
AU726143B2 (en) 2000-11-02
JP2001505181A (ja) 2001-04-17
AR006202A1 (es) 1999-08-11
ZA971607B (en) 1998-08-25
AU1987597A (en) 1997-10-01
EP0904108A1 (en) 1999-03-31
WO1997033616A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
AU4582797A (en) Methods for treatment of retinal diseases
PL338551A1 (en) Method of and compocition for treating late-phase allergic reactions and diseases associated with inflammatory state
EP0907369A4 (en) MATERIALS AND METHODS FOR TREATING MULTIPLE DISEASES
AU7622198A (en) Methods of treating mental diseases, inflammation and pain
ZA977263B (en) Treatment of upper airway allergic responses.
PL329851A1 (en) Treatment of diseases associated with vegf
AU2058697A (en) Treatment of sleep disorders
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
HK1026096A1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
IL126113A0 (en) Methods for treatment of allergic diseases with ige
EP1039883A4 (en) METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
PL336760A1 (en) Treatment of skin diseases
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
IL133089A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU5425098A (en) Compounds and methods to treat infectious diseases
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AUPN115095A0 (en) Analysis of and compositions and methods for the treatment of disease
GB9522221D0 (en) Compounds for use in treatment of ige mediated allergic diseases
GB2324962B (en) Treatment of allergic conditions
GB9709451D0 (en) Treatment of allergic conditions
AU3163795A (en) Treatment of autoimmune diseases